Discontinuation symptoms after treatment with serotonin reuptake inhibitors: A literature review

Journal of Clinical Psychiatry

Volumn 58, Issue 7, 1997, Pages 291-297

  Zajecka, John ^a   Tracy, Katherine A ^a   Mitchell, Sunny ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; NEFAZODONE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

AGITATION; ANXIETY; ARTICLE; CLINICAL TRIAL; DEPRESSION; FATIGUE; HEADACHE; HUMAN; INSOMNIA; NAUSEA; PRIORITY JOURNAL; SENSORY DYSFUNCTION; VERTIGO; WITHDRAWAL SYNDROME;

EID: 0030795390     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v58n0702     Document Type: Article

References (36)

1. Dilsaver SC, Greden JF. Antidepressant withdrawal phenomena. Biol Psychiatry 1984;19:237-256
2. Dilsaver SC, Greden JF, Snider RM. Antidepressant withdrawal syndromes: phenomenology and pathophysiology. Int Clin Psychopharmacol 1987;2:1-19
3. Goodwin FK, Jamison KR. Manic Depressive Illness. New York, NY: Oxford University Press; 1990
4. Rosenblatt JE, Rosenblatt NC. Toxicology and drug interactions. Currents in Affective Illness 1994;13:15-17
5. Rosenblatt JE, Rosenblatt NC. Toxicology and drug interactions. Currents in Affective Illness 1996;15:3-4
6. Fava GA, Grandi S. Withdrawal syndromes after paroxetine and sertraline discontinuation [letter]. J Clin Psychopharmacol 1995;15(5):374-375
7. Pyke RE. Paroxetine withdrawal syndrome [letter]. Am J Psychiatry 1995; 152:149-150
8. Phillips SD. A possible paroxetine withdrawal syndrome [letter]. Am J Psychiatry 1995;152:645-646
9. DeBattista C, Schatzberg AF. Physical symptoms associated with paroxetine withdrawal [letter]. Am J Psychiatry 1995;152:1235-1236
10. Frost L, Lal S. Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors [letter]. Am J Psychiatry 1995;152:810
11. Dominguez RA, Goodnick PJ. Adverse events after the abrupt discontinuation of paroxetine. Pharmacotherapy 1995;15:778-780
12. Louie AK, Lannon RA, Ajari LJ. Withdrawal reaction after sertraline discontinuation [letter]. Am J Psychiatry 1994;151:450-451
13. Leiter FL, Nierenberg AA, Sanders KM, et al. Discontinuation reactions following sertraline. Biol Psychiatry 1995;38:694-695
14. Farah A, Lauer TE. Possible venlafaxine withdrawal syndrome [letter]. Am J Psychiatry 1996;153:576
15. Szabadi E. Fluvoxamine withdrawal syndrome [letter]. Br J Psychiatry 1992;160:283-284
16. Berlin CS. Fluoxetine withdrawal symptoms [letter]. J Clin Psychiatry 1996;57:93-94
17. Einbinder E. Fluoxetine withdrawal? [letter] Am J Psychiatry 1995;152: 1235
18. Stoukides JA, Stoukides CA. Extrapyramidal symptoms upon discontinuation of fluoxetine [letter]. Am J Psychiatry 1991;148:1263
19. Ellison JM. SSRI withdrawal buzz [letter]. J Clin Psychiatry 1994;55: 544-545
20. Coupland NJ, Bell CJ, Potokar JP. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 1996;16:356-362
21. Barr LC, Goodman WK, Price LH. Physical symptoms associated with paroxetine discontinuation [letter]. Am J Psychiatry 1994;151:289
22. Keuthen NJ, Cyr P, Ricciardi JA, et al. Medication withdrawal symptoms in obsessive compulsive disorder patients treated with paroxetine [letter]. J Clin Psychopharmacol 1994;14:206-207
23. Bloch M, Stager SV, Braun AR, et al. Severe psychiatric symptoms associated with paroxetine withdrawal [letter]. Lancet 1995;346:57
24. Oehrberg S, Christiansen PE, Behnke K, et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study. Br J Psychiatry 1995;167:374-379
25. Choo V. Paroxetine and extrapyramidal reactions [letter]. Lancet 1993; 341:624
26. Paxil (paroxetine). Physicians' Desk Reference. 50th ed. Montvale, NJ: Medical Economics; 1996:2505-2508
27. Mallya G, White K, Gunderson C. Is there a serotonergic withdrawal syndrome? [letter] Biol Psychiatry 1993;33:851-852
28. Black DW, Wesner R, Gabel J. The abrupt discontinuation of fluvoxamine in patients with panic disorder. J Clin Psychiatry 1993;54:146-149
29. Rauch SL, O'Sullivan RL, Jenike MA. Open treatment of obsessive compulsive disorder with venlafaxine: a series often cases [letter]. J Clin Psychopharmacol 1996;16:81-83
30. Kreider MS, Bushnell WD, Oakes R, et al. A double-blind, randomized study to provide safety information on switching fluoxetine-treated patients to paroxetine without an intervening washout period. J Clin Psychiatry 1995;56:142-145
31. Kent LSW, Laidlaw JDD. Suspected congenital sertraline dependence. Br J Psychiatry 1995;167:412-413
32. Ratan DA, Friedman T. Antidepressants in pregnancy and breastfeeding [letter]. Br J Psychiatry 1995;167:824
33. Goldstein DJ. Effects of third trimester fluoxetine exposure on the newborn. J Clin Psychopharmacol 1995;15:417-420
34. Lazowick AL, Levin GM. Potential withdrawal syndrome associated with SSRI discontinuation. Ann Pharmacother 1995;29:1284-1285
35. Fava GA. Holding on: depression, sensitization by antidepressant drugs, and the prodigal experts. Psychother Psychosom 1995;64:57-61
36. Baldessarini RJ. Risks and implications of interrupting maintenance psychotropic drug therapy. Psychother Psychosom 1995;63:137-141